Kato Y, Watanabe K, Nakakura M, Hosokawa T, Hayakawa E, Ito K
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Chem Pharm Bull (Tokyo). 1993 Mar;41(3):599-604. doi: 10.1248/cpb.41.599.
The in vivo elimination and tissue distribution (2 h after administration) of various types of formulations of alpha-tocopherol as a model drug were examined in rats. An organic cosolvents formulation of alpha-tocopherol (alpha-tocopherol/EtOH/polyethylene glycol 400) was rapidly removed from the blood circulation, the ratio of the distributed alpha-tocopherol was 20% in the lungs, about 70% in the liver and about 10% in the spleen. The main reason for this was considered to be the appearance of droplets more than 10 microns in diameter in the blood. Elimination of the micelle formulation using Brij58 from the blood was the most rapid, followed by Tween80 and HCO60. This order is thought to be due to the difference in the polyoxyethylene group among these surfactants. In liposome formulations, liposomes having a diameter of about 80 nm were the most stable in the blood circulation, and alpha-tocopherol was distributed in the reticuloendothelial system (RES) in the smallest ratio. The uptake of liposomes by the spleen and lungs depended on the liposome size. The uptake by the liver was in the decreasing order of 28 nm >> 42 nm, 151 nm, 195 nm, 3656 nm > 106 nm > 75 nm. The 100 nm lipid emulsion was eliminated from the blood more rapidly than the 100 nm liposome formulation.
以α-生育酚作为模型药物,研究了大鼠体内不同类型制剂的消除和组织分布(给药后2小时)情况。α-生育酚的有机助溶剂制剂(α-生育酚/乙醇/聚乙二醇400)从血液循环中快速清除,α-生育酚的分布比例在肺中为20%,在肝脏中约为70%,在脾脏中约为10%。主要原因被认为是血液中出现了直径超过10微米的液滴。使用Brij58的胶束制剂从血液中的消除速度最快,其次是吐温80和HCO60。这种顺序被认为是由于这些表面活性剂中聚氧乙烯基团的差异。在脂质体制剂中,直径约80纳米的脂质体在血液循环中最稳定,α-生育酚在网状内皮系统(RES)中的分布比例最小。脾脏和肺对脂质体的摄取取决于脂质体大小。肝脏对脂质体的摄取顺序为28纳米>>42纳米、151纳米、195纳米、3656纳米>106纳米>75纳米。100纳米的脂质乳剂从血液中的消除速度比100纳米的脂质体制剂更快。